CHRISTINE VIEIRA: Open Payments
NPI 1063820645 · ONTARIO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,344 in 62 payments from 14 companies in 2025. Trend: 2023 $2,508 · 2024 $3,565 · 2025 $3,344
Food & beverage: $3,344
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $598 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $474 |
| Alkermes, Inc. | 5 | $397 |
| Axsome Therapeutics, Inc. | 6 | $393 |
| Vanda Pharmaceuticals Inc. | 3 | $371 |
| E.R. Squibb & Sons, L.L.C. | 3 | $370 |
| Braeburn Inc. | 3 | $266 |
| Teva Pharmaceuticals USA, Inc. | 1 | $124 |
| Janssen Pharmaceuticals, Inc | 1 | $109 |
| Otsuka America Pharmaceutical, Inc. | 1 | $105 |
Products named: VRAYLAR, CAPLYTA, Auvelity, FANAPT, COBENFY, BRIXADI, ARISTADA, LYBALVI.
Industry payments across NY — which companies pay providers there.
